Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -8,735 | -4,986 | -3,495 | N/A |
| Depreciation Amortization | 301 | 281 | 277 | N/A |
| Accounts payable and accrued liabilities | 1,042 | 291 | 48 | N/A |
| Other Working Capital | 2,325 | 3,223 | 2,182 | N/A |
| Other Operating Activity | 838 | 27 | 278 | 0 |
| Operating Cash Flow | $-4,229 | $-1,164 | $-710 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -500 | -9 | -25 | N/A |
| Net Acquisitions | N/A | 1,329 | N/A | N/A |
| Sale Of Investment | 815 | N/A | N/A | N/A |
| Investing Cash Flow | $315 | $1,320 | $-25 | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 11,653 | N/A | N/A | N/A |
| Financing Cash Flow | $11,653 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 257 | 101 | 836 | N/A |
| End Cash Position | 7,996 | 257 | 101 | N/A |
| Net Cash Flow | $7,739 | $156 | $-735 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -4,229 | -1,164 | -710 | N/A |
| Capital Expenditure | -500 | -9 | -25 | N/A |
| Free Cash Flow | -4,729 | -1,173 | -735 | 0 |